International Alliance for Primary Immunodeficiency Societies


LASID is proud to partner with other international societies focused on primary immunodeficiency representing the five major continents. Together they have formed the International Alliance for Primary Immunodeficiency Societies (IAPIDS).

 

The agreement made by the Asia-Pacific Society of Immunodeficiencies (APSID), African Society for Immunodeficiencies (ASID), Clinical Immunology Society (CIS), and the European Society for Immunodeficiencies (ESID), as well as the LASID was signed and announced at the ESID Annual Meeting in Barcelona, Spain on September 21, 2016.

 

The IAPIDS exists to advance the member professional societies in education of those engaged in the care of PID patients and promote member societies in disseminating and advancing the basic, translational and clinical science of PID and related knowledge all in the name of advancing the well-being and care of patients affected by PID and related conditions.

International Alliance for Primary Immunodeficiency Societies

International Alliance for Primary Immunodeficiency Societies Mission statement

The International Alliance for Primary Immunodeficiency Societies exists to advance the member professional societies in education of those engaged in the care of PID patients and promote member societies in disseminating and advancing the basic, translational and clinical science of PID and related knowledge all in the name of advancing the well-being and care of patients affected by PID and related conditions.

International Alliance for Primary Immunodeficiency Societies Cooperative Leadership Agreement

  1. The purpose of International Alliance for Primary Immunodeficiency Societies is in advancing its mission in accordance with its cooperative agreement.
  2. International Alliance for Primary Immunodeficiency Societies member societies are committed to advancing the mission of the alliance.
  3. Current International Alliance for Primary Immunodeficiency Societies member societies are APSID, ASID, CIS, ESID, and LASID.
  4. International Alliance for Primary Immunodeficiency Societies is a non-fundraising entity. Fundraising is the domain of International Alliance for Primary Immunodeficiency Societies member organizations in promotion of their individual missions.
  5. Each International Alliance for Primary Immunodeficiency Societies member society will focus upon education, dissemination of knowledge, and promotion of best clinical practice as well as basic, translational and clinical research in PID for its individual regional constituencies and within its individual regions.
  6. International Alliance for Primary Immunodeficiency Societies member societies agree to communicate with each other transparently through the leadership of the individual member societies.
  7. International Alliance for Primary Immunodeficiency Societies member societies will hold either annual or biennial regional meetings.
  8. International Alliance for Primary Immunodeficiency Societies member societies will take great care to ensure non-overlap in calendar scheduling of regional meetings with those of other International Alliance for Primary Immunodeficiency Societies society meetings.
  9. Members of any International Alliance for Primary Immunodeficiency Societies member society will be offered member pricing to the annual or biennial meeting of any other International Alliance for Primary Immunodeficiency Societies member society.
  10. International Alliance for Primary Immunodeficiency Societies member societies will aspire to hold didactic/interactive “schools” to facilitate the educational development of their present and future regional constituents.
  11. International Alliance for Primary Immunodeficiency Societies member societies and the International Alliance for Primary Immunodeficiency Societies itself are committed to working with transnational organizations, patient or otherwise, in advancing the interests of PID and related fields.
  12. International Alliance for Primary Immunodeficiency Societies member societies commit to working with patient organizations, medical and scientific societies in their regions to promote education in PID and ultimately further advancement of PID patient well-being.
  13. Cooperative leadership for International Alliance for Primary Immunodeficiency Societies is via communication between the standing President, incoming (elect) or Vice-President, and Immediate Past President of the individual International Alliance for Primary Immunodeficiency Societies member societies.
  14. Communication amongst International Alliance for Primary Immunodeficiency Societies leadership will formally occur no less than biannually and can be virtual or in person appreciating that the former is likely to always be more practical.
  15. Decisions on behalf of International Alliance for Primary Immunodeficiency Societies or modifications to the cooperative agreement are made by majority vote of those in cooperative leadership.
  16. Individual International Alliance for Primary Immunodeficiency Societies member societies remain as independent entities responsible to their own boards, bylaws and governance.
Scroll to Top